The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,804.00
Bid: 1,813.00
Ask: 1,816.00
Change: 14.00 (0.78%)
Spread: 3.00 (0.165%)
Open: 1,788.00
High: 1,827.00
Low: 1,770.00
Prev. Close: 1,790.00
JMAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Johnson Matthey business update

7 Feb 2018 07:00

RNS Number : 0785E
Johnson Matthey PLC
07 February 2018
 

Johnson Matthey business update

 

Johnson Matthey today provides an update on two business matters: the settlement of the contract dispute lawsuit reported as a contingent liability in November 2017; and the positive impact of US tax legislation on the group.

Settlement of after treatment contract lawsuit

As announced on 21st November 2017, a group company, Johnson Matthey Inc. (JMI), had been made a defendant to a contract dispute lawsuit alongside a supplier to an automotive OEM in the United States. The dispute related to a component supplied by the group. We reported a contingent liability in relation to the lawsuit in the announcement of our half year results for the six months ended 30th September 2017.

 

Today we announce that the lawsuit against JMI has been settled on mutually acceptable terms with no admission of fault. Under this settlement agreement, Johnson Matthey will recognise a charge of £50 million in connection with resolution of the lawsuit. This charge will be excluded from underlying operating profit for the year ending 31st March 2018.

 

Positive impact of US tax legislation on Johnson Matthey

We note the approval of the US Tax Cuts and Jobs Act, which became generally effective 1st January 2018, and expect to be positively impacted by these changes.

 

The lowering of the US corporate tax rate leads to a revaluation of our US deferred tax liabilities, which we estimate will result in a £30 million one-off non-cash benefit in the income tax expense line in the income statement for the year ending 31st March 2018. This will be excluded from the tax on underlying profit.

 

For the current financial year to 31st March 2018, we anticipate no change to the effective tax rate on underlying profit. We continue to expect this to be around 18%. Looking forward to the financial year ending 31st March 2019 and beyond we expect these changes will reduce the effective tax rate on underlying profit by around two percentage points. We continue to work through the full impact and will give more detail in our preliminary announcement for the year ending 31st March 2018.

 

Outlook

Our outlook for the year ending 31st March 2018 remains unchanged.

 

Enquiries:

Analysts and investors:

Martin Dunwoodie +44 (0)20 7269 8241

Simon McGough +44 (0)20 7269 8235

Katharine Burrow +44 (0)20 7269 8444

Media:

Sally Jones +44 (0)20 7269 8407

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDTFMJTMBAMBIP
Date   Source Headline
11th Oct 202210:00 amRNSHolding(s) in Company
11th Oct 20227:00 amRNSHolding(s) in Company
30th Sep 20222:56 pmRNSHolding(s) in Company
30th Sep 202212:17 pmRNSHolding(s) in Company
30th Sep 202211:34 amRNSDirector/PDMR Shareholding
29th Sep 202210:18 amRNSHolding(s) in Company
27th Sep 20224:23 pmRNSHolding(s) in Company
26th Sep 20223:35 pmRNSHolding(s) in Company
22nd Sep 20223:38 pmRNSDirector/PDMR Shareholding
20th Sep 20224:31 pmRNSHolding(s) in Company
20th Sep 20223:30 pmRNSDirector/PDMR Shareholding
20th Sep 20222:27 pmRNSHolding(s) in Company
15th Sep 202210:28 amRNSHolding(s) in Company
7th Sep 20229:49 amRNSHolding(s) in Company
2nd Sep 20224:22 pmRNSHolding(s) in Company
1st Sep 20229:42 amRNSTotal Voting Rights
30th Aug 202212:37 pmRNSHolding(s) in Company
30th Aug 202212:26 pmRNSHolding(s) in Company
26th Aug 20229:37 amRNSHolding(s) in Company
25th Aug 20223:19 pmRNSHolding(s) in Company
25th Aug 20222:28 pmRNSHolding(s) in Company
24th Aug 202210:55 amRNSHolding(s) in Company
22nd Aug 202212:20 pmRNSHolding(s) in Company
18th Aug 20223:57 pmRNSDirector/PDMR Shareholding
17th Aug 20224:16 pmRNSHolding(s) in Company
15th Aug 20225:23 pmRNSHolding(s) in Company
15th Aug 202212:39 pmRNSHolding(s) in Company
11th Aug 20223:57 pmRNSDirector/PDMR Shareholding
11th Aug 20223:45 pmRNSDirector/PDMR Shareholding
11th Aug 20228:30 amRNSHolding(s) in Company
10th Aug 20223:53 pmRNSDirector/PDMR Shareholding
9th Aug 20222:31 pmRNSHolding(s) in Company
5th Aug 202211:10 amRNSHolding(s) in Company
3rd Aug 20224:31 pmRNSDirector/PDMR Shareholding
3rd Aug 20224:23 pmRNSDirector/PDMR Shareholding
3rd Aug 20224:21 pmRNSDirector/PDMR Shareholding
3rd Aug 20224:04 pmRNSDirector/PDMR Shareholding
3rd Aug 20223:59 pmRNSDirector/PDMR Shareholding
3rd Aug 20223:50 pmRNSDirector/PDMR Shareholding
3rd Aug 20223:41 pmRNSDirector/PDMR Shareholding
1st Aug 20227:00 amRNSJM restated HY numbers for new reporting structure
29th Jul 20222:49 pmRNSHolding(s) in Company
27th Jul 20224:15 pmRNSHolding(s) in Company
27th Jul 20224:00 pmRNSHolding(s) in Company
26th Jul 20223:00 pmRNSHolding(s) in Company
22nd Jul 20223:23 pmRNSDirector/PDMR Shareholding
21st Jul 20224:00 pmRNSResult of AGM
18th Jul 202211:00 amRNSHolding(s) in Company
18th Jul 20227:00 amRNSJohnson Matthey announces new hydrogen gigafactory
15th Jul 20229:12 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.